Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

HCW Biologics Inc. Common Stock (HCWB)

Pharmaceutical Preparations

https://www.hcwbiologics.com

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

2929 N COMMERCE PKWY
MIRAMAR, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/20/2021

Market Cap

19,668,168

Shares Outstanding

35,980,000

Weighted SO

35,974,570

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ANEB --.--%

RZLT --.--%

ELYM --.--%

MOLN --.--%

MNOV --.--%

CSBR --.--%

CYT --.--%

PMVP --.--%

PHVS --.--%

Beta

0.8170

Last Div

0.0000

Range

0.5-2.181

Chg

0.0110

Avg Vol

17406

Mkt Cap

19668168

Exch

NASDAQ

Country

US

Phone

954 842 2024

DCF Diff

0.7112

DCF

-0.1992

Div Yield

0.0000

P/S

5.0140

EV Multiple

-1.1135

P/FV

-3.1220

Div Yield %

0.0000

P/E

-0.5126

PEG

0.0072

Payout

0.0000

Current Ratio

0.1028

Quick Ratio

0.1028

Cash Ratio

0.0500

DSO

60.9445

DIO

0.0000

Op Cycle

60.9445

DPO

1839.9461

CCC

-1779.0016

Gross Margin

0.1465

Op Margin

-6.8277

Pretax Margin

-9.7809

Net Margin

-9.7809

Eff Tax Rate

0.0052

ROA

-1.4305

ROE

-3.8590

ROCE

-7.4377

NI/EBT

1.0000

EBT/EBIT

1.4325

EBIT/Rev

-6.8277

Debt Ratio

0.3738

D/E

-1.5913

LT Debt/Cap

2.7495

Total Debt/Cap

2.6913

Int Coverage

408.4285

CF/Debt

-1.7906

Equity Multi

-4.2573

Rec Turnover

5.9891

Pay Turnover

0.1984

Inv Turnover

0.0000

FA Turnover

0.1720

Asset Turnover

0.1463

OCF/Share

-0.4746

FCF/Share

-0.5924

Cash/Share

0.0307

OCF/Sales

-4.5760

FCF/OCF

1.2483

CF Coverage

-1.7906

ST Coverage

-144.8106

CapEx Coverage

-4.0275

Div&CapEx Cov

-4.0275

P/BV

-3.1220

P/B

-3.1220

P/S

5.0140

P/E

-0.5126

P/FCF

-0.8778

P/OCF

-1.0957

P/CF

-1.0957

PEG

0.0072

P/S

5.0140

EV Multiple

-1.1135

P/FV

-3.1220

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 14, 00:01 HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Benzinga Nov 19, 02:27 HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules GlobeNewswire Inc. Nov 19, 02:27 HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules Benzinga Nov 27, 13:41 Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session GlobeNewswire Inc. Nov 08, 07:30 Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Revenue Product Segmentation